Zobrazeno 1 - 10
of 54
pro vyhledávání: '"Z. S. Valieva"'
Autor:
S. A. Musashaykhova, Z. S. Valieva, A. K. Osokina, I. Z. Korobkova, V. V. Gramovich, N. M. Danilov, T. V. Martynyuk
Publikováno v:
Евразийский Кардиологический Журнал, Vol 0, Iss 4, Pp 74-81 (2022)
Modern pathogenetic therapy of idiopathic pulmonary arterial hypertension (IPAH), a severe life-threatening cardiovascular disease of unknown etiology, leads to a positive clinical effect due to reverse remodeling of the vessels of the microvasculatu
Externí odkaz:
https://doaj.org/article/c863d9d7f08d4d9791a8af2cbbb45589
Publikováno v:
Евразийский Кардиологический Журнал, Vol 0, Iss 4, Pp 68-73 (2022)
The case of a 81-year-old male with atrial fibrillation, associated with severe aortic stenosis (AS) is outlined. A peculiarity of the clinical portrait of AS is a long asymptomatic period with a significantly varying duration. After the appearance o
Externí odkaz:
https://doaj.org/article/ddd43de499284d49b7a08da18e8a54f8
Autor:
I. E. Chazova, S. V. Gorbachevskij, T. V. Martynyuk, A. A. Shmal’c, Z. S. Valieva, I. Yu. Baryshnikova, L. A. Glushko, V. V. Gramovich, V. A. Azizov, T. N. Veselova, N. M. Danilov, P. A. Zelveyan, S. N. Ivanov, I. V. Lazareva, Yu. G. Matchin, M. A. Mukarov, S. N. Nakonechnikov, A. Sh. Sarybaev, O. V. Stukalova, S. V. Shalaev
Publikováno v:
Евразийский Кардиологический Журнал, Vol 0, Iss 2, Pp 6-70 (2022)
Externí odkaz:
https://doaj.org/article/f099f1c9583745efadb1c534dfdedd8e
Publikováno v:
Евразийский Кардиологический Журнал, Vol 0, Iss 1, Pp 80-89 (2022)
Symposium dedicated to pulmonary arterial hypertension took place at the 9th Russian Congress on Pulmonary hypertension on December 14, 2021. In this review key points from Chazova I.E., Martynyuk T.V., Valieva Z.S., Gramovich V.V.`s reports are pres
Externí odkaz:
https://doaj.org/article/6adbafdc45784d7e9dc50f6dfa79e504
Autor:
I. E. Chazova, T. V. Martynyuk, Z. S. Valieva, V. A. Azizov, R. S. Akchurin, A. A. Ansheles, O. Ya. Vasiltseva, T. N. Veselova, A. S. Galyavich, S. V. Gorbachevsky, N. M. Danilov, A. G. Edemskiy, P. A. Zelveyan, I. V. Lazareva, Yu. G. Matchin, K. V. Mershin, M. A. Mukarov, S. N. Nakonechnikov, M. A. Saidova, A. Sh. Sarybaev, V. B. Sergienko, O. V. Stukalova, E. V. Filippov, A. M. Chernyavsky, M. A. Chernyavsky, S. V. Shalaev, A. A. Shmalts
Publikováno v:
Евразийский Кардиологический Журнал, Vol 0, Iss 1, Pp 6-43 (2021)
Disclaimer The EAC Guidelines represent the views of the EAC, and were produced after careful consideration of the scientific and medical knowledge, and the evidence available at the time of their publication. The EAC is not responsible in the event
Externí odkaz:
https://doaj.org/article/a13d1258009e48e0a0b46a800b1474fe
Publikováno v:
Терапевтический архив, Vol 92, Iss 9, Pp 77-84 (2020)
Currently, treatment of pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) is focused on three signaling pathways: the NO pathway, the endothelin pathway, and the prostacyclin pathway. Riociguat is the onl
Externí odkaz:
https://doaj.org/article/2c8b0f60993c49bfb4a70e783ef64510
Autor:
I. E. Chazova, T. V. Martynyuk, Z. S. Valieva, V. A. Azizov, O. L. Barbarash, T. N. Veselova, A. S. Galyavich, S. V. Gorbachevsky, P. A. Zelveian, I. V. Lazareva, M. A. Mukarov, S. N. Nakonetchnikov, M. A. Saidova, A. Sh. Sarybaev, O. V. Stukalova, S. V. Shalaev, A. A. Shmalts
Publikováno v:
Евразийский Кардиологический Журнал, Vol 0, Iss 1, Pp 78-122 (2020)
Externí odkaz:
https://doaj.org/article/37870b29cc8e4e3787c7b268f2da2a80
Autor:
Z. S. Valieva, T. V. Martynyuk
Publikováno v:
Евразийский Кардиологический Журнал, Vol 0, Iss 4, Pp 144-155 (2019)
Idiopathic pulmonary arterial hypertension (IPAH) is a rather rare cardiovascular disease of unknown origin and, at the same time, the most common form of pulmonary arterial hypertension (PAH). It is characterized by increased mean pulmonary artery p
Externí odkaz:
https://doaj.org/article/5209084e7a3e4f1fbb77214a0a3abcce
Publikováno v:
Евразийский Кардиологический Журнал, Vol 0, Iss 4, Pp 86-99 (2017)
In recent years the information about relevance of cardiopulmonary exercise testing (CPET) in complex assessment of pulmonary arterial hypertension (PAH) patients and chronic thromboembolic pulmonary hypertension (CTEPH) patients have been accumulati
Externí odkaz:
https://doaj.org/article/01b23de4a96540048457efbc6294b76c
Autor:
I. N. Taran, V. M. Paramonov, Z. S. Valieva, M. A. Saidova, S. N. Nakonechnikov, T. V. Martynyuk, I. Ye. Chazova
Publikováno v:
Евразийский Кардиологический Журнал, Vol 0, Iss 4, Pp 84-93 (2016)
SUMMERY The patient with diagnosis of idiopathic pulmonary hypertension, functional class III (WHO) was treated by anticoagulants, diuretics. After 6 months of treatment with phosphodiesterase type 5-inhibitor sildenafil, there was observed the negat
Externí odkaz:
https://doaj.org/article/3676441ad0e146bf976e7335f052df20